Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice

Behavioural Brain Research

Volumn 224, Issue 1, 2011, Pages 44-49

  Kost, Sara ^a   Sun, Chao ^a   Xiong, Wei ^a   Graham, Kathryn ^c   Cass, Carol E ^c   Young, James D ^c   Albensi, Benedict C ^a,b   Parkinson, Fiona E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenosine receptor; Caffeine; Equilibrative nucleoside transporter 1; Ethanol; Real time PCR

Indexed keywords

ALCOHOL; CAFFEINE; DNA; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1;

ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SYNAPTOSOME; TRANSGENE;

ADENOSINE KINASE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CEREBRAL CORTEX; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; ETHANOL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PROTEIN BINDING; THIOINOSINE; TRITIUM;

EID: 79958780983     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.05.023     Document Type: Article

References (22)

1. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 2001, 38:107-125.
2. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int Rev Neurobiol 2005, 63:191-270.
3. Zamzow C.R., Xiong W., Parkinson F.E. Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes. J Neurosci Res 2008, 86:3447-3455.
4. Parkinson F.E., Xiong W. Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J Neurochem 2004, 88:1305-1312.
5. Anderson C.M., Baldwin S.A., Young J.D., Cass C.E., Parkinson F.E. Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res Mol Brain Res 1999, 70:293-297.
6. Anderson C.M., Xiong W., Geiger J.D., Young J.D., Cass C.E., Baldwin S.A., et al. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 1999, 73:867-873.
7. Parkinson F.E., Xiong W., Zamzow C.R., Chestley T., Mizuno T., Duckworth M.L. Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. J Neurochem 2009, 109:562-572.
8. Bachmann H.S., Siffert W., Frey U.H. Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique. Pharmacogenetics 2003, 13:759-766.
9. Jennings L.L., Hao C., Cabrita M.A., Vickers M.F., Baldwin S.A., Young J.D., et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 2001, 40:722-731.
10. Haurogne K., Bach J.M., Lieubeau B. Easy and rapid method of zygosity determination in transgenic mice by SYBR((R)) Green real-time quantitative PCR with a simple data analysis. Transgenic Res 2007, 16:127-131.
11. King A.E., Ackley M.A., Cass C.E., Young J.D., Baldwin S.A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 2006, 27:416-425.
12. Alexander S.P., Mathie A., Peters J.A. Guide to receptors and channels, 2nd edition. Br J Pharmacol 2006, 147(Suppl.3):S1-S168.
13. Zhang D., Xiong W., Albensi B.C., Parkinson F.E. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J Neurochem 2011, 10.1111/j.1471-4159.2011.07242.x.
14. Damaraju V.L., Elwi A.N., Hunter C., Carpenter P., Santos C., Barron G.M., et al. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am J Physiol Renal Physiol 2007, 293:F200-F211.
15. Nagy L.E., Diamond I., Casso D.J., Franklin C., Gordon A.S. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 1990, 265:1946-1951.
16. Krauss S.W., Ghirnikar R.B., Diamond I., Gordon A.S. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol Pharmacol 1993, 44:1021-1026.
17. Carmichael F.J., Israel Y., Crawford M., Minhas K., Saldivia V., Sandrin S., et al. Central nervous system effects of acetate: contribution to the central effects of ethanol. J Pharmacol Exp Ther 1991, 259:403-408.
18. + ATPase. Neuropsychopharmacology 2010, 35:1984-1996.
19. Puglia M.P., Valenzuela C.F. Ethanol acutely inhibits ionotropic glutamate receptor-mediated responses and long-term potentiation in the developing CA1 hippocampus. Alcohol Clin Exp Res 2010, 34:594-606.
20. Dar M.S. Central adenosinergic system involvement in ethanol-induced motor incoordination in mice. J Pharmacol Exp Ther 1990, 255:1202-1209.
21. Choi D.S., Cascini M.G., Mailliard W., Young H., Paredes P., McMahon T., et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 2004, 7:855-861.
22. Fredholm B.B. Astra award lecture adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995, 76:93-101.